Browsing by 키워드 : Renal cell carcinoma
전체 결과 11건 중 1-11 번을 표시중입니다.
- 1 Article Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial Sumanta K Pal ; Javier Puente ; Daniel Y C Heng ; et al 2022
- 2 Article Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy Jongpil Lee ; Jungyo Suh ; Cheryn Song ; et al 2022
- 3 Article Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey Joongwon Choi ; Cheryn Song ; Jungyo Suh ; et al 2023
- 4 Article Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma Jeffrey Graham ; 이재련 ; Aaron Hansen ; et al 2020
- 5 Article Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma Dongsu Kim ; Bumjin Lim ; Jungyo Suh ; et al 2023
-
6
dissertation
Exploration of tumor microenvironment using multiplexed immunohistochemistry and its association with response in advanced or metastatic renal cell carcinoma treated with immune checkpoint inhibitors
김좌훈
2022
- 7 Article Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors 이재련 ; 황인환 ; 박인근 ; et al 2020
- 8 Article Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study Do-Youn Oh ; Maria Alsina Maqueda ; David I Quinn ; et al 2023
- 9 Article PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI-Resistant Metastatic Clear Cell Renal Cell Carcinoma Se Un Jeong ; Hee Sang Hwang ; Ja-Min Park ; et al 2023
- 10 Article Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial Laurence Albiges ; Howard Gurney ; Vagif Atduev ; et al 2023
- 11 Article Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell lines 김동진 ; 김소명 ; 김소원 ; et al 2021
1